BSE filing, NSE: VADILENT. Summary written from the filing by ALFA Finder's alert engine.
Vadilal Enterprises Ltd: key numbers
- Share price
- ₹9,500.00
- Market cap
- ₹819.6 Cr
- Revenue (annual)
- ₹1,217 Cr
- Net profit (annual)
- ₹10.45 Cr
- P/E (TTM)
- 60.0×Sector 39.0×
- Promoter holding
- 51.03%+0.00% QoQ
- FII holding
- 0.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vadilal Enterprises Ltd
All →Vadilal Enterprises Annual General Meeting
Vadilal Enterprises' EGM approved execution of a sale and purchase agreement with Vadilal Industries Limited. No transaction value was disclosed.
Vadilal Enterprises Board Meeting Date
Vadilal Enterprises Ltd intimated a Board meeting on October 30, 2026, to approve Q1 and H1 FY27 Ind AS results. Trading window remains closed until November 1.
Vadilal Enterprises Other Announcement
Routine quarterly shareholding pattern disclosure for Vadilal Enterprises Ltd as of September 30, 2026, filed in compliance with SEBI Regulation 31(1)(b).
Vadilal Enterprises Annual General Meeting
Vadilal Enterprises Limited has issued a notice for an Extra-Ordinary General Meeting scheduled for October 27, 2026. The meeting seeks shareholder approval for a supply agreement with Vadilal Industries Limited.
- Execution
- 12 months
Vadilal Enterprises Partnership
Vadilal Enterprises Ltd reached a fresh supply agreement with Vadilal Industries Limited valid until October 2027. The agreement ensures business continuity following previous shareholder rejection of a renewal.
- From
- Vadilal Industries Limited
- Execution
- Up to October 31, 2027
Vadilal Enterprises Board Meeting Outcome
Vadilal Enterprises Limited's board has approved convening an Extra Ordinary General Meeting on October 27, 2026. The meeting will be conducted via video conferencing with a record date of October 20, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.